======= GNAQ ======= == Gene Information == * **Official Symbol**: GNAQ * **Official Name**: G protein subunit alpha q * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2776|2776]] * **UniProt**: [[https://www.uniprot.org/uniprot/P50148|P50148]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GNAQ&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GNAQ|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600998|Open OMIM]] == Function Summary == * **Entrez Summary**: This locus encodes a guanine nucleotide-binding protein. The encoded protein, an alpha subunit in the Gq class, couples a seven-transmembrane domain receptor to activation of phospolipase C-beta. Mutations at this locus have been associated with problems in platelet activation and aggregation. A related pseudogene exists on chromosome 2.[provided by RefSeq, Nov 2010]. * **UniProt Summary**: Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. Regulates B-cell selection and survival and is required to prevent B-cell-dependent autoimmunity. Regulates chemotaxis of BM-derived neutrophils and dendritic cells (in vitro) (By similarity). {ECO:0000250}. |G-alpha| |Arf| |type 2A serotonin receptor binding| |phototransduction, visible light| |G protein-coupled acetylcholine receptor signaling pathway| |G-protein beta/gamma-subunit complex binding| |entrainment of circadian clock| |acetylcholine receptor signaling pathway| |heterotrimeric G-protein complex| |activation of phospholipase C activity| |response to acetylcholine| |cellular response to acetylcholine| |postsynaptic signal transduction| |positive regulation of phospholipase C activity| |phototransduction| |glutamate receptor signaling pathway| |regulation of phospholipase C activity| |detection of visible light| |positive regulation of phospholipase activity| |detection of light stimulus| |photoreceptor outer segment| |G protein-coupled receptor binding| |positive regulation of lipase activity| |regulation of phospholipase activity| |signal transduction involved in cellular response to ammonium ion| |action potential| |regulation of lipase activity| |regulation of circadian rhythm| |detection of external stimulus| |detection of abiotic stimulus| |adenylate cyclase-activating G protein-coupled receptor signaling pathway| |cellular response to ammonium ion| |platelet activation| |cAMP-mediated signaling| |cyclic-nucleotide-mediated signaling| |protein stabilization| |response to ammonium ion| |adenylate cyclase-modulating G protein-coupled receptor signaling pathway| |negative regulation of protein kinase activity| |nuclear membrane| |negative regulation of kinase activity| |G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger| |negative regulation of transferase activity| |regulation of canonical Wnt signaling pathway| |GTPase activator activity| |regulation of protein stability| |blood coagulation| |coagulation| |hemostasis| |lysosomal membrane| |response to light stimulus| |GTPase activity| |second-messenger-mediated signaling| |regulation of Wnt signaling pathway| |GTP binding| |cellular response to drug| |negative regulation of protein phosphorylation| |positive regulation of GTPase activity| |regulation of membrane potential| |response to radiation| |negative regulation of phosphorylation| |synaptic signaling| |wound healing| |regulation of GTPase activity| |regulation of body fluid levels| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |response to wounding| |negative regulation of protein modification process| |cellular response to hormone stimulus| |cellular response to nitrogen compound| |detection of stimulus| |positive regulation of hydrolase activity| |negative regulation of catalytic activity| |regulation of protein kinase activity| |regulation of kinase activity| |response to hormone| |regulation of transferase activity| |response to drug| |negative regulation of cellular protein metabolic process| |cellular response to oxygen-containing compound| |cell activation| |response to nitrogen compound| |negative regulation of protein metabolic process| |cell-cell signaling| |negative regulation of molecular function| |response to abiotic stimulus| |cellular response to endogenous stimulus| |regulation of hydrolase activity| |G protein-coupled receptor signaling pathway| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |response to endogenous stimulus| |response to oxygen-containing compound| |regulation of phosphorylation| |intracellular signal transduction| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|1.77| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 3/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|1/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|1/22| |urinary tract|1/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10336 * **Expression level (log2 read counts)**: 0.0 {{:chemogenomics:nalm6 dist.png?nolink |}}